JPMorgan Chase & Co’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $24.5M | Buy |
|
|||||
|
2020
Q4 | $2.87M | Sell |
|
|||||
|
2020
Q3 | $928K | Buy |
|
|||||
|
2020
Q2 | $1.15M | Sell |
|
|||||
|
2020
Q1 | $463K | Sell |
|
|||||
|
2019
Q4 | $2.43M | Buy |
|
|||||
|
2019
Q3 | $1.57M | Buy |
|
|||||
|
2019
Q2 | $1.95M | Buy |
|
|||||
|
2019
Q1 | $3.26M | Sell |
|
|||||
|
2018
Q4 | $2.28M | Sell |
|
|||||
|
2018
Q3 | $3.59M | Buy |
|
|||||
|
2018
Q2 | $3.81M | Sell |
|
|||||
|
2018
Q1 | $6.06M | Sell |
|
|||||
|
2017
Q4 | $8.37M | Buy |
|
|||||
|
2017
Q3 | $11.1M | Sell |
|
|||||
|
2017
Q2 | $8.98M | Buy |
|
|||||
|
2017
Q1 | $4.1M | Sell |
|
|||||
|
2016
Q4 | $7.79M | Buy |
|
|||||
|
2016
Q3 | $6.81M | Buy |
|
|||||
|
2016
Q2 | $3.33M | Buy |
|
|||||
|
2016
Q1 | $6K | Hold |
|
|||||
|
2015
Q4 | $6K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $197K | Buy |
|